Cost-effectiveness of empagliflozin in heart failure patients irrespective of ejection fraction in England

por Kolovos, Spyros, Bellanca, Leana, Groyer, Harinala, Rosano, Giuseppe, Gaultney, Jennifer, Linden, Stephan
Publicado 2023

Multinational cost‐effectiveness analysis of empagliflozin for heart failure patients with ejection fraction >40%

por Kolovos, Spyros, Bellanca, Leana, Groyer, Harinala, Rosano, Giuseppe M.C., Solé, Alexandra, Gaultney, Jennifer, Linden, Stephan
Publicado 2023

Cost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States...

por Kauf, Teresa L, Prabhu, Vimalanand S., Medic, Goran, Borse, Rebekah H., Miller, Benjamin, Gaultney, Jennifer, Sen, Shuvayu S., Basu, Anirban
Publicado 2017

Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer

por Peters, Michel L., de Meijer, Claudine, Wyndaele, Dirk, Noordzij, Walter, Leliveld-Kors, Annemarie M., van den Bosch, Joan, van den Berg, Pieter H., Baka, Agni, Gaultney, Jennifer G.
Publicado 2017

Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer

por Peters, Michel L., de Meijer, Claudine, Wyndaele, Dirk, Noordzij, Walter, Leliveld-Kors, Annemarie M., van den Bosch, Joan, van den Berg, Pieter H., Baka, Agni, Gaultney, Jennifer G.
Publicado 2018